A Report of 212 Male Renal Transplant Recipients Who Fathered 216 Offspring after Transplantation

Long-Gen Xu,Li-Ming Jin,Xiao-Feng Zhu,Qi-Zhe Song,Xian-Fan Ding,Shu Han,You-Hua Zhu,Yong Liu,Hong-Wei Wang,Jing Fu,Yi-Rong Yang,Feng Qiu,Wan-Ling Peng,Li-Gong Tang,Nian-Qing Lu

DOI: https://doi.org/10.1097/tp.0b013e31818c95a7

2008-01-01

Transplantation

Abstract:Progress in transplantation permits patient with kidney failure to survive and to father children. Since approximately 40% of men receiving a kidney transplant are younger than 50 (1), it is important to determine the waiting period before fathering after transplantation with concern about the effect of immunosuppression on the offspring. Like healthy males, male recipients of renal transplants can father children no apparent significant effect on the offspring, on the recipients’ overall health, or on the functioning of the transplanted kidney (2). Two years waiting period after transplantation has been considered appropriate for initiation of pregnancy (3). This, however, needs to be confirmed in a large sample size. We report here a retrospective analysis of 212 male renal transplant recipients from eight transplant centers in China who were transplanted between December 1981 and August 2007 and who fathered 216 children after transplantation. Of these 211 received the kidney for the first time while one received a second transplant. Primary diseases included 207 patients with chronic glomerulonephritis and five with renal hypertension, course of 1 to 108 (20.50±19.1) months. The duration of dialysis treatment was 1 to 62 months with 189 patients treated with maintenance hemodialysis, whereas 23 were treated with peritoneal dialysis. Immunosuppressive drugs used during the period of fertilization were as follows: CsA 1.2 to 3.0 mg/kg/day, FK506 0.03 to 0.1 mg/kg/day, Aza 50 to 75 mg/day, Pred 5 to 10 mg/day, MMF 1.0 to 1.5 g/day. The combination of CsA+Aza+Pred was used in 161 patients, whereas 31 patients received CsA+MMF+Pred and 14 were treated with FK506+MMF+Pred. Two patients were treated with FK506+MMF and only one patient received Aza+Pred. This study was approved by the ethics committee of the authors’ hospitals, and all recipients signed informed consents. Two hundred twelve renal transplant recipients fathered 216 children 15 to 204 (46.91±26.19) months after transplantation. Their renal function remained normal during the period of fertility, the offsprings included 115 boys, 101 girls, and four sets of twins. Ninety-seven children were delivered by cesarean section and the remaining 119 were delivered by natural birth; 9 (4.2%) babies were preterm births. The newborn babies weighed 1950 to 4600 (3253±379) g, similar to the reported weights of normal babies. There was no correlation between immunosuppression and the children’s weight at birth. In contrast, 20 recipients fathered 20 offspring earlier, at 15 to 24 (21.00±2.94) months after transplantation. This group included three preterm births (15.0%). The remaining 192 recipients fathered 196 offspring 25 to 204 (49.56±26.06) months after transplantation. This group included six preterm births (3.1%). All babies were breast-fed after birth and none of the children had birth asphyxia. By history all children developed normally except one boy who suffered from a pair of soft toes. In conclusion, it would be appropriated for male renal transplant recipients with normal renal function to wait 2 years after transplantation to father a child. Such waiting period resulted in babies without any significant side effects on the growth and development of offsprings. Long-Gen Xu Li-Ming Jin Xiao-Feng Zhu Qi-Zhe Song Xian-Fan Ding Center for Renal Transplantation The 117th Hospital, Hangzhou Zhejiang, China Shu Han You-Hua Zhu Institute of Organ Transplantation Long-March Hospital Shanghai, China Yong Liu Department of Urology The 1st People’s Hospital affiliated to Shanghai Jiaotong University Shanghai, China Hong-Wei Wang Jing Fu The 2nd Hospital affiliated to Shandong University Jinan, Shandong, China Yi-Rong Yang Transplantation Center The 1st Hospital affiliated to Wenzhou Medical College Wenzhou, Zhejiang, China Feng Qiu Department of Transplantation Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China Wan-Ling Peng Department of Urology The 153rd Hospital Zhengzhou, Henan, China Li-Gong Tang Department of Urology Wuhan General Hospital Wuhan, Hubei, China Nian-Qing Lu Jiangsu Family Planning Research Institute Nanjing, China